Evidence map›Paper›PMID 40292750›Full record

ArticleClinical and translational medicine2025

Enhancing the safety and efficacy of cell therapy with programmed sense-and-respond function.

Andrew J Walters, Xiaoyu Yang, Scott D Olson, Caleb J Bashor

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew J Walters *Department of Bioengineering, Rice University, Houston, Texas, USA.
Xiaoyu Yang *Department of Bioengineering, Rice University, Houston, Texas, USA.
Scott D OlsonDepartment of Pediatric Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-8032-3755
Caleb J BashorDepartment of Bioengineering, Rice University, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-1354-2098

Funding

Synthetic toolkit for precision gene expression control and signal processing in mammalian cellsR01EB029483 · NIBIB · HARVARD UNIVERSITY · PI Ahmad Samir Khalil · 2020 to 2026
$5.0M
A synthetic signaling pathway engineering platform for creating precision cell-based sense-and-response devicesR01EB032272 · NIBIB · RICE UNIVERSITY · PI BASHOR, CALEB · 2021 to 2024
$1.4M
Reshaping MSC surface expression profiles to target inflammation following CNS traumaR21NS116302 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI OLSON, SCOTT D · 2020 to 2020
$434k
National Science Foundation 1842494NIBIB NIH HHS R01 EB029483NIBIB NIH HHS R01 EB032272NIH HHS EB029483NIH HHS EB032272NIH HHS NS116302NINDS NIH HHS R21 NS116302Office of Naval Research N00014-21-1-4006Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40292750
PMCPMC12035645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.